23andMe launches new diabetes risk test, but experts are wary of its benefit

23andMe launches new diabetes risk test, but experts are wary of its benefit

In contrast to its previous FDA approvals for genetic risk tests for conditions like Alzheimer’s, Parkinson’s Disease and colorectal cancer, the diabetes assessment was did not go through the FDA clearance pathway because it was characterized as a wellness product not intended to make diagnoses and provide medical advice. 

Source: https://ift.tt/2HqeTsN